- Why There Is No Published Passing Number
- How Passing Points Are Actually Set
- What Gets Scored: Phase I vs. Phase II
- Format, Points and Why Totals Are Not Question Counts
- Domain Coverage You Must Master
- 2026 Delivery, Fees and the Eligibility Clock
- Retakes, Fees and the Cost of Missing the Mark
- Sequencing Your Preparation Around the Domains
- What Is Verified and What Is Not
- Frequently Asked Questions
- No fixed numerical DACVCP pass mark has been verified; passing points are recommended by the Examination Committee and ad hoc reviewers for Board approval.
- Phase I is 200 multiple-choice questions in two 100-question sessions; Phase II is worth 200 points across two 100-point sessions.
- Both phases must be passed within a five-year eligibility window that starts with the first eligible examination year after Phase I approval.
- 2026 Phase I (May 19) and Phase II (June 30) were delivered remotely via ExamSoft; a 2027 schedule was not verified.
Why There Is No Published Passing Number
Candidates searching for "the DACVCP passing score" usually expect a single figure, such as a percentage or a scaled number, that they can aim for. For the Diplomate, American College of Veterinary Clinical Pharmacology (DACVCP), that figure has not been verified in the public materials of the American College of Veterinary Clinical Pharmacology (ACVCP). A fixed numerical pass mark and a current pass rate were both unconfirmed at the time of this writing, and this article will not invent either one.
This is not unusual for a small specialty board. What it means in practice is that the honest answer to "what do I need to pass?" is a description of process and preparation breadth, not a magic number. If you want the broader difficulty picture, see our companion piece How Hard Is the DACVCP Exam? Complete Difficulty Guide 2026, and for what is and is not known about outcomes, read DACVCP Pass Rate 2026: What the Data Shows.
How Passing Points Are Actually Set
The published description of the process is straightforward: passing points are recommended by the Examination Committee and ad hoc reviewers, and then submitted for Board approval. Two practical implications follow from that wording.
- Judgment-based, not purely formulaic. Expert reviewers are involved in recommending the threshold, which means the mark can reflect the content and difficulty of the specific administration rather than a universal constant.
- Board approval is the final step. The passing point is not final until the Board signs off, so there is no way for a candidate to compute a guaranteed target in advance.
The right preparation mindset, therefore, is to aim for command of the full content outline rather than a calculated minimum. Candidates who plan around "just enough" are working against a threshold nobody can confirm.
What Gets Scored: Phase I vs. Phase II
The complete credential requires both Phase I and Phase II, and the two phases are scored on different kinds of evidence. Keeping them straight matters, because "passing" means something different at each stage.
| Feature | Phase I | Phase II |
|---|---|---|
| Question types | Multiple choice only | Written responses, multiple choice, fill-in-the-blank and extended matching |
| Structure | 200 questions in two 100-question sessions | Ten question groups, worth 200 points across two 100-point sessions |
| Ordinary schedule | 08:00-12:00 and 14:00-18:00 local time | Ordinary schedule also provides eight active hours |
| Scored unit | Individual questions | Points (not a question count) |
| 2026 date | May 19 | June 30 |
| Prerequisite | Approved residency enrollment or completion; two references | Phase I pass, approved credentials, accepted or published papers |
Because Phase II mixes constructed-response and selected-response formats, partial credit and grader judgment can play a role that simply does not exist in Phase I. That is another reason a single "percent correct" figure would be misleading across the whole credential.
Format, Points and Why Totals Are Not Question Counts
One of the most common misreadings of the Phase II format is treating "200 points" as "200 questions." The ACVCP describes Phase II as ten question groups worth 200 points in total, split into two 100-point sessions. A single group may contain several items, and a written-response item may carry far more points than a multiple-choice item. Do not assume equal weighting of items.
Phase I is simpler to reason about: 200 multiple-choice questions, two sessions of 100, with a break between them. That is eight active examination hours across the day, excluding the break.
Domain Coverage You Must Master
Because no fixed pass mark is published, breadth of preparation is your real protection. The 22 preparation headings below come from a dated Phase I suggested blueprint (last revised December 2021), which has not been confirmed as the current exam outline. The four categories that follow come from the current Phase II examination page, which does not publish category percentages. Treat all of these as a preparation curriculum, not a verified weighted blueprint. For a full walkthrough, see DACVCP Exam Domains 2026: Complete Guide to All 26 Content Areas.
Foundations: Domains 1-9
The core principles that underpin everything else on the exam.
- Physiochemical characteristics of active pharmaceutical ingredients (note the source spelling "Physiochemical")
- Pharmacodynamics
- Drug movement
- Pharmacokinetics
- Factors impacting drug movement and/or drug response
- Routes of administration
- Dosing forms (and relevant drug delivery devices)
- Adverse events
- Causes for therapeutic failure
Organ Systems and Drug Classes: Domains 10-22
System-based and class-based pharmacology across veterinary species.
- Nervous System
- Renal
- Cardiovascular
- Gastrointestinal
- Reproduction
- Endocrine
- General and special senses
- Control of inflammation/immunomodulation
- Anticancer drugs
- Fluid therapy
- Anti-infectives
- Botanical/Herbals
- Disinfectants/antiseptics
Phase II Examination Categories: Domains 23-26
The four subject categories listed on the current Phase II examination page; percentages are not published there.
- Therapeutics
- Pharmacokinetics and Therapeutic Drug Monitoring
- Experimental Design, Statistics and Analytical Methods
- Regulatory Pharmacology
Note the shift in emphasis. The first 22 headings are mechanistic and content-heavy, which fits Phase I's multiple-choice format. The four Phase II categories lean toward application: designing and interpreting studies, applying kinetics to monitoring decisions, and navigating regulatory frameworks. A candidate strong in drug classes but weak in statistics or study design is exposed on Phase II. The DACVCP Cheat Sheet 2026: One-Page Review of Must-Know Facts is a useful companion for rapid review of the foundational concepts.
2026 Delivery, Fees and the Eligibility Clock
Remote delivery in 2026
The Candidate Information page published the 2026 administration: Phase I on May 19 and Phase II on June 30, both delivered remotely using ExamSoft. Both dates have now passed, and a 2027 schedule was not verified, so check the ACVCP site for current timing. This dated notice takes precedence over generic phase-page language that mentions a testing location or on-site practice. For timing details, see DACVCP Exam Dates 2026: Testing Windows, Deadlines & Scheduling.
Candidates supply a compatible Windows or Mac laptop with Examplify installed and administrator privileges. The encrypted examination is downloaded in advance and unlocked with a proctor password, and examination mode blocks internet access, files and other applications. Advance practice examinations are available, and using them is part of passing: they let you rehearse the software and become familiar with question structure before the real sitting.
Published 2026 fees
| Item | Published 2026 amount |
|---|---|
| Phase I application | USD 75 |
| Phase I examination | USD 200 |
| Phase II credentials review | USD 250 |
| Phase II examination | USD 300 |
A separate page on becoming a resident calls USD 75 a first-year candidate registration fee. The public pages do not establish whether that is identical to, or additional to, the Phase I application charge, so confirm with the ACVCP before budgeting. For the complete cost picture, see DACVCP Certification Cost 2026: Complete Pricing Breakdown.
The five-year eligibility window
Both phases must be passed within a five-year eligibility period that begins with the first eligible examination year after Phase I approval. The issuer's own example: approval in December 2025 permits the 2026-2030 examinations. This is an examination eligibility window, not credential renewal.
Key Takeaway
Your real "passing score" deadline is the end of your five-year window. Plan Phase I and Phase II attempts so that at least one retake of each remains possible inside the window, and track the October 1 application and February 1 intent-to-sit and paper deadlines for each examination year.
Retakes, Fees and the Cost of Missing the Mark
Retakes require payment of the respective examination fee again. On refunds, the sources are not perfectly aligned: the general fee page permits refunds only for extenuating circumstances accepted by the Board, while the phase pages describe examination fees as nonrefundable. Plan as though fees are nonrefundable.
The financial penalty of a miss is modest compared with the calendar penalty. Because the examinations are offered on an annual cycle with ordinary application deadlines of October 1 before the examination year, a miss can cost a full year of your five-year window. Phase II adds further prerequisites that cannot be rushed: two peer-reviewed papers accepted or published by February 1 of the examination year, at least one being original veterinary clinical pharmacology research and at least one with you as first author. See DACVCP Requirements 2026: Eligibility, Prerequisites & How to Qualify for the full prerequisite chain.
Sequencing Your Preparation Around the Domains
Since the threshold is unpublished, the best strategy is coverage with depth in the areas that cascade into others. A reasonable ordering follows the logic of the content itself: kinetics and dynamics first, because they feed every organ-system and drug-class topic that follows.
Quantitative foundations
- Physiochemical characteristics, pharmacodynamics, drug movement, pharmacokinetics
- Practice kinetic calculations until they are automatic
Variation and failure
- Factors impacting drug movement and response, routes of administration, dosing forms and delivery devices
- Adverse events and causes for therapeutic failure
Organ systems and classes
- Nervous, renal, cardiovascular, GI, reproductive, endocrine, senses
- Anti-infectives, anticancer drugs, inflammation/immunomodulation, fluid therapy, botanicals, disinfectants
Phase II application skills
- Therapeutic drug monitoring scenarios, experimental design, statistics, regulatory pharmacology
- Timed written responses and extended-matching practice
For a fuller plan, see DACVCP Study Guide 2026: How to Pass on Your First Attempt. You can also drill question styles with the DACVCP practice tests on the main site, which is one way to rehearse the Examplify-style experience described above.
What Is Verified and What Is Not
Because other sites sometimes blur the line, here is a clear separation for this credential.
| Verified from ACVCP public pages | Not verified |
|---|---|
| Phase I: 200 multiple-choice questions, two 100-question sessions | A fixed numerical pass mark for either phase |
| Phase II: ten question groups, 200 points, two 100-point sessions | A current pass rate |
| Passing points recommended by the Examination Committee and ad hoc reviewers for Board approval | Current percentage weights for exam categories |
| 2026 dates (May 19 and June 30) and remote ExamSoft delivery | A 2027 examination schedule |
| Published 2026 fees and five-year eligibility window | Current renewal hours, fees or interval |
One related point: the current Phase I and Phase II blueprint downloads could not be retrieved during verification, and older legacy blueprint files carry a December 2021 revision date. The domain headings above are therefore dated preparation content. If the ACVCP issues an updated blueprint, that document controls.
Maintenance of certification is a separate matter from examination passing. A Maintenance of Certification committee administers recertification, but the detailed page requires authorization and historical bylaw text (approved June 2018) should not be read as current renewal rules. No renewal interval or hours are asserted here. For the career side of the credential, read Is the DACVCP Certification Worth It? Complete ROI Analysis 2026 and DACVCP Jobs.
Frequently Asked Questions
No fixed numerical passing score has been verified in public ACVCP materials. Passing points are recommended by the Examination Committee and ad hoc reviewers and then approved by the Board, so prepare for full content coverage rather than a specific percentage.
No. Phase II is worth 200 points across two 100-point sessions and is organized into ten question groups. The point total is not a question count, and item types include written responses, multiple choice, fill-in-the-blank and extended matching.
You may retake, but each retake requires the respective examination fee (USD 200 for Phase I and USD 300 for Phase II in the published 2026 cycle). Both phases must still be passed within your five-year eligibility window.
The ACVCP's dated 2026 notice states both phases were delivered remotely using ExamSoft, with Phase I on May 19 and Phase II on June 30. Those dates have passed, and a 2027 schedule was not verified.
No current weightings are published. The first 22 headings come from a dated December 2021 Phase I blueprint, and the four Phase II categories come from the current examination page without percentages. Treat all 26 as a preparation curriculum.